Cutting edge oncology research progresses more quickly than anticipated
Redx Pharma reaches pre-clinical proof of concept stage with oncology lead Chronic Lymphocytic Leukaemia (CLL) patients commonly develop resistance to gold-standard?therapy (the?irreversible Bruton…
